Metoprolol: analysis of first-line medication for cardiovascular disease

Metoprolol is a selective β1-blocker widely used in the treatment of hypertension, angina, arrhythmias and heart failure. This article will start from the dimensions of pharmacological effects, clinical applications, precautions and manufacturers, focusing on analyzing its core functions and usage specifications. The content is divided into five parts: first, an overview of the drug, then a detailed discussion of the indications and mechanisms, then an analysis of medication precautions, then an introduction to common preparations on the market, and finally a summary of its clinical value.

Pharmacological mechanism and core indications

Metoprolol reduces myocardial contractility and heart rate by blocking cardiac β1 receptors, thereby reducing myocardial oxygen consumption. itsThree core indicationsIncluding: 1) hypertension (can be used alone or in combination); 2) stable angina (improve myocardial ischemia); 3) treatment after acute myocardial infarction (reduce mortality). Clinical data shows that the drug can reduce the mortality rate of patients with myocardial infarction by approximately 36% (quoted from the European Society of Cardiology Guidelines). The therapeutic dose usually starts from 25-50 mg/day and is gradually adjusted according to the efficacy.

Medication precautions for special populations

When using metoprolol, you need to be alert to the risk of bronchospasm, and patients with asthma should use it with caution. May occur while taking medicationCommon adverse reactions: Fatigue (incidence about 10%), dizziness (6-10%), bradycardia (5%). Blood pressure needs to be monitored when used in combination with other antihypertensive drugs. Sudden discontinuation of the drug may cause rebound angina. The U.S. FDA specifically reminds that use during pregnancy requires weighing the pros and cons (category C risk), and use should be suspended during lactation.

Mainstream preparations and manufacturers in the market

Summary of clinical status and rational drug use

As a basic drug for cardiovascular diseases, metoprolol is irreplaceable in improving prognosis. Clinical use must follow the principle of "initiating at a low dose and making individual adjustments", and pay attention to drug interactions (such as avoiding combination with verapamil). China's "Guidelines for the Prevention and Treatment of Hypertension" lists it as a preferred β-blocker. When used correctly, this drug can significantly improve the patient's quality of life, but it needs to be used under the guidance of a doctor.

Quote sources:
1. "European Society of Cardiology Guidelines" 2016 Edition
2. U.S. FDA drug insert (Metoprolol Succinate)
3. China's "Guidelines for the Prevention and Treatment of Hypertension" 2018 revised edition
4. AstraZeneca Pharmaceuticals Ltd. Product Brochure